NanoSphere Health Sciences Inc.
NSHS
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.75% | -2.43% | -2.16% | -18.93% | -35.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.76% | -14.42% | -8.68% | -23.27% | -33.17% |
| Operating Income | 8.76% | 14.42% | 8.68% | 23.27% | 33.17% |
| Income Before Tax | 243.17% | 227.11% | 196.06% | 215.38% | 25.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 243.17% | 227.11% | 196.06% | 215.38% | 25.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 243.17% | 227.11% | 196.06% | 215.38% | 25.41% |
| EBIT | 8.76% | 14.42% | 8.68% | 23.27% | 33.17% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 244.04% | 228.13% | 196.65% | 216.29% | 25.48% |
| Normalized Basic EPS | -11.67% | -26.67% | -36.64% | -4.32% | 26.38% |
| EPS Diluted | 244.04% | 228.13% | 196.65% | 216.29% | 25.48% |
| Normalized Diluted EPS | -11.67% | -26.67% | -36.64% | -4.32% | 26.38% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |